[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346553-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346553-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","npm1-drives-erk12-dependent-tumor-progression-in-lung-cancer","NPM1 Drives ERK1/2-dependent Tumor Progression in Lung Cancer","","Lung cancer remains the leading cause of cancer-related mortality, requiring dependable biomarkers for earlier diagnosis and improved therapies. Nucleophosmin 1 (NPM1) is implicated in cancer biology, but its role in lung cancer and its connection to ERK1/2 activation are unclear. Using TCGA transcriptomic data, siRNA-based NPM1 knockdown in A549/H1299 cells, and functional assays in vitro and in vivo, the study evaluates proliferation, colony formation, signaling changes, and tumorigenicity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/npm1-drives-erk12-dependent-tumor-progression-in-lung-cancer/346553/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/npm1-drives-erk12-dependent-tumor-progression-in-lung-cancer/346553.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study on NPM1 in lung cancer?","Question",{"text":63,"@type":64},"To determine whether NPM1 drives lung cancer progression and how it relates to ERK1/2 pathway activation in lung cancer cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers assess NPM1 expression and its effects?",{"text":68,"@type":64},"They analyzed TCGA transcriptomic data for expression in lung cancer versus normal tissues, then used siRNA-mediated NPM1 silencing in A549 and H1299 cells and evaluated proliferation, soft agar colony formation, and signaling by western blot.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanistic link did the study find between NPM1 and ERK1/2 signaling?",{"text":72,"@type":64},"NPM1 knockdown decreased phosphorylation of ERK1/2, indicating that NPM1 promotes ERK1/2 pathway activation during lung cancer progression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346553,1790914714,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","doi: 10.21873/cgp.20572  \nNPM1 Drives ERK1/2-dependent Tumor  \nProgression in Lung Cancer  \nHONG-BEUM KIM1, HEE-JEONG LEE2 and SANG-GON PARK2  \n1 Department of Premedical Course, Chosun University School of Medicine, Gwangju, Republic of Korea; 2 Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Republic of Korea  \nAbstract  \nBackground/Aim: Lung cancer is the most lethal malignancy worldwide, and there remains an urgent need for reliable biomarkers to improve diagnosis and treatment. Nucleophosmin 1 (NPM1), a nucleolar phosphoprotein, has been implicated in hematological cancers, but its significance in lung cancer is less clear. This study investigated the oncogenic role ofNPM1 in lung cancer and its involvement in ERK1/2 pathway activation in lung cancer cells. Materials and Methods: Transcriptomic data from TCGA were analyzed to assess NPM1 expression in lung cancer and normal tissues. In vitro assays using A549 and H1299 cells were conducted following siRNA-mediated silencing of NPM1. Cell proliferation, soft agar colony formation, and western blot analyses were performed. In vivo tumorigenicity was tested using a nude mouse xenograft model.  \nResults: NPM1 expression was significantly elevated in lung cancer tissues compared with normal samples. Silencing NPM1 reduced proliferation, colony formation, and tumor growth. Mechanistic studies revealed that NPM1 knockdown decreased phosphorylation ofERK1/2, indicating its role in activating this pathway.  \nConclusion: NPM1 contributes to lung cancer progression via ERK1/2 signaling. These results highlight NPM1 as a novel oncogene and suggest its potential as a diagnostic and prognostic biomarker in lung cancer.  \nKeywords: Nucleophosmin 1 (NPM1), lung cancer, ERK1/2 signaling, oncogene, diagnostic biomarker.  \nIntroduction  \nLung cancer remains the leading cause of cancer-related mortality worldwide, accounting for approximately 1.8 million deaths annually, and its incidence continues to rise despite advances in early detection and treatment (1) .  \nAlthough recent developments in targeted therapies and immunotherapies have improved outcomes for selected patients, the overall five-year survival rate for advanced lung cancer remains below 20%(2, 3) . Therefore, identifying actionable molecular drivers and reliable biomarkers is essential to enhance early detection,  \n✉ Sang-Gon Park, MD, PhD, Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, 365 Pilmun-daero,  \nDong-gu, Gwangju, 61453, Republic of Korea. Tel: +82 622203984, Fax: +82 622349653, e-mail: [sgpark@chosun.ac.kr](sgpark@chosun.ac.kr)  \nReceived October 31, 2025 | Revised November 25, 2025 | Accepted December 4, 2025  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \nimprove prognostic accuracy, and develop more effective therapeutic strategies.  \nNucleophosmin 1 (NPM1) is a multifunctional nucleolar phosphoprotein that shuttles between the nucleolus and cytoplasm and participates in ribosomal RNA processing, centrosome duplication, chromatin remodeling, and transcriptional regulation (4, 5) . Mutations in the NPM1 gene are well recognized as defining events in acute myeloid leukemia (AML), where they serve as diagnostic and prognostic markers (6) . Beyond hematologic malignancies, aberrant NPM1 expression has been reported in several solid tumors, including gastric, colorectal, and breast cancers, where its overexpression correlates with enhanced tumor aggressiveness and poor patient survival (7-9) . Recent studies have further linked NPM1 to the regulation of the tumor immune microenvironment, m6A RNA modification, and metabolic reprogramming, highlighting its pleiotropic oncogenic potentia","cbCaicmm0Q6MQtgI","https://ap.wps.com/l/cbCaicmm0Q6MQtgI","pdf",2206890,"English","# Abstract\n## Background/Aim\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the main objective of the study on NPM1 in lung cancer?\",\"answer\":\"To determine whether NPM1 drives lung cancer progression and how it relates to ERK1/2 pathway activation in lung cancer cells.\"},{\"question\":\"How did the researchers assess NPM1 expression and its effects?\",\"answer\":\"They analyzed TCGA transcriptomic data for expression in lung cancer versus normal tissues, then used siRNA-mediated NPM1 silencing in A549 and H1299 cells and evaluated proliferation, soft agar colony formation, and signaling by western blot.\"},{\"question\":\"What mechanistic link did the study find between NPM1 and ERK1/2 signaling?\",\"answer\":\"NPM1 knockdown decreased phosphorylation of ERK1/2, indicating that NPM1 promotes ERK1/2 pathway activation during lung cancer progression.\"}]","NPM1 Drives ERK1/2-dependent Tumor Progression in Lung Cancer | PDF",1790061948,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4839125e7c2b14a622e43cf9c8af9cde.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ebf71e4cd54e49aca9b3fa2d80b273a.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e4ffbdc99c4b3c9bfcebc595760bf61.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/253856b7710cf9dc5fabede6bc065139.webp",980,1306]